bioAffinity Technologies has filed a notice of an exempt offering of securities to raise $1,302,084.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, bioAffinity Technologies is raising up to $1,302,084.00 in new funding. Sources indicate that as part of senior management President and Chief Executive Officer, Maria Zannes…